Cargando…

Predictive value of LncRNA on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis

BACKGROUND. Evidence shows that long-stranded non-coding RNA (LncRNA) can predict coronary artery restenosis in patients suffering from coronary heart disease after percutaneous coronary intervention, suggesting that LncRNA may become a promising biomarker for the diagnosis of coronary artery resten...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shengxiang, Yang, Guokang, Huang, Yupeng, Zhang, Cheng, Jin, Hongyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793375/
https://www.ncbi.nlm.nih.gov/pubmed/33429779
http://dx.doi.org/10.1097/MD.0000000000024114
_version_ 1783633976095670272
author Liu, Shengxiang
Yang, Guokang
Huang, Yupeng
Zhang, Cheng
Jin, Hongyan
author_facet Liu, Shengxiang
Yang, Guokang
Huang, Yupeng
Zhang, Cheng
Jin, Hongyan
author_sort Liu, Shengxiang
collection PubMed
description BACKGROUND. Evidence shows that long-stranded non-coding RNA (LncRNA) can predict coronary artery restenosis in patients suffering from coronary heart disease after percutaneous coronary intervention, suggesting that LncRNA may become a promising biomarker for the diagnosis of coronary artery restenosis after percutaneous coronary intervention. However, its accuracy has not been systematically evaluated. Therefore, it is necessary to perform meta-analysis to certify the diagnostic value of LncRNA on coronary artery restenosis after percutaneous coronary intervention. METHODS. PubMed, EMBASE, Cochrane Library, and Web of Science were searched for relevant studies to explore the potential diagnostic values of LncRNA on coronary artery restenosis after percutaneous coronary intervention from inception to December 2020. Data were extracted by two experienced researchers independently. The risk of bias about the meta-analysis was confirmed by the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2). Data was synthesized and heterogeneity was investigated as well. All of the above statistical analysis was carried out with Stata 14.0. RESULTS. This study proved the pooled diagnostic performance of LncRNA on coronary artery restenosis after percutaneous coronary intervention. CONCLUSION. This study clarified confusions about the specificity and sensitivity of LncRNA on coronary artery restenosis after percutaneous coronary intervention, thus further guiding their promotion and application. ETHICS AND DISSEMINATION. Ethical approval is not required for this study. The systematic review will be published in a peer-reviewed journal, presented at conferences, and shared on social media platforms. This review would be disseminated in a peer-reviewed journal or conference presentations. OSF REGISTRATION NUMBER: DOI 10.17605/OSF.IO/4QT2P.
format Online
Article
Text
id pubmed-7793375
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-77933752021-01-11 Predictive value of LncRNA on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis Liu, Shengxiang Yang, Guokang Huang, Yupeng Zhang, Cheng Jin, Hongyan Medicine (Baltimore) 3400 BACKGROUND. Evidence shows that long-stranded non-coding RNA (LncRNA) can predict coronary artery restenosis in patients suffering from coronary heart disease after percutaneous coronary intervention, suggesting that LncRNA may become a promising biomarker for the diagnosis of coronary artery restenosis after percutaneous coronary intervention. However, its accuracy has not been systematically evaluated. Therefore, it is necessary to perform meta-analysis to certify the diagnostic value of LncRNA on coronary artery restenosis after percutaneous coronary intervention. METHODS. PubMed, EMBASE, Cochrane Library, and Web of Science were searched for relevant studies to explore the potential diagnostic values of LncRNA on coronary artery restenosis after percutaneous coronary intervention from inception to December 2020. Data were extracted by two experienced researchers independently. The risk of bias about the meta-analysis was confirmed by the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2). Data was synthesized and heterogeneity was investigated as well. All of the above statistical analysis was carried out with Stata 14.0. RESULTS. This study proved the pooled diagnostic performance of LncRNA on coronary artery restenosis after percutaneous coronary intervention. CONCLUSION. This study clarified confusions about the specificity and sensitivity of LncRNA on coronary artery restenosis after percutaneous coronary intervention, thus further guiding their promotion and application. ETHICS AND DISSEMINATION. Ethical approval is not required for this study. The systematic review will be published in a peer-reviewed journal, presented at conferences, and shared on social media platforms. This review would be disseminated in a peer-reviewed journal or conference presentations. OSF REGISTRATION NUMBER: DOI 10.17605/OSF.IO/4QT2P. Lippincott Williams & Wilkins 2021-01-08 /pmc/articles/PMC7793375/ /pubmed/33429779 http://dx.doi.org/10.1097/MD.0000000000024114 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 3400
Liu, Shengxiang
Yang, Guokang
Huang, Yupeng
Zhang, Cheng
Jin, Hongyan
Predictive value of LncRNA on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
title Predictive value of LncRNA on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
title_full Predictive value of LncRNA on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
title_fullStr Predictive value of LncRNA on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
title_full_unstemmed Predictive value of LncRNA on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
title_short Predictive value of LncRNA on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
title_sort predictive value of lncrna on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: a protocol for systematic review and meta-analysis
topic 3400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793375/
https://www.ncbi.nlm.nih.gov/pubmed/33429779
http://dx.doi.org/10.1097/MD.0000000000024114
work_keys_str_mv AT liushengxiang predictivevalueoflncrnaoncoronaryrestenosisafterpercutaneouscoronaryinterventioninpatientswithcoronaryheartdiseaseaprotocolforsystematicreviewandmetaanalysis
AT yangguokang predictivevalueoflncrnaoncoronaryrestenosisafterpercutaneouscoronaryinterventioninpatientswithcoronaryheartdiseaseaprotocolforsystematicreviewandmetaanalysis
AT huangyupeng predictivevalueoflncrnaoncoronaryrestenosisafterpercutaneouscoronaryinterventioninpatientswithcoronaryheartdiseaseaprotocolforsystematicreviewandmetaanalysis
AT zhangcheng predictivevalueoflncrnaoncoronaryrestenosisafterpercutaneouscoronaryinterventioninpatientswithcoronaryheartdiseaseaprotocolforsystematicreviewandmetaanalysis
AT jinhongyan predictivevalueoflncrnaoncoronaryrestenosisafterpercutaneouscoronaryinterventioninpatientswithcoronaryheartdiseaseaprotocolforsystematicreviewandmetaanalysis